Tulane Home Tulane Shield logo linking to site home page

LCRC Biobank


Mission Statement

… to collect high quality samples of normal and diseased human material with appropriate pathologic annotations and to make this material available to researchers ...

High quality refers not only to the biological quality of tissue and accompanying pathological data, but also to the ethical and legal status under which donors are enrolled and consented. 

Biospecimen Inventory

Tissue Site Total # Cases African-American
# Cases
Caucasian # Cases
Prostate 703 230 473
Kidney 190   55 135
Head and Neck 165   53 112
Breast 144   82   62
GI   70   58   12
Thyroid   67   25   42
Leukemias/Lymphomas   51   14   33
OB-GYN   50   26   24
Liver   32   14   18
Pancreas   24     8   16
Biospecimen Core / Tulane Collaborative Projects

  • Glycosidases as Related to Sphingolipidoses.
    Dr.Yu-The Li, Ph.D.
  • Evaluation of the Presence of Urinary Biomarkers in Prostate Cancer.
    Asim Abdel-Mageed, D.V.M., Ph.D.
  • Mutation Rate in Prostate Cancer.
    Nick Makridakis, Ph.D.
  • Association of Genetic Variants with Prostate Cancer Risk in African Americans.
    Oliver Sartor, M.D.
  • Altered pattern of TRPML Expression in Human Breast and Prostate Tumor Tissues.
    Ming Li, Ph.D.
  • Steroidogenic Factor-1: A Putative Suppressor of Ovarian Cancer.
    Meera Ramayya, M.D, M.S.
  • Genomic Instability in Prostate Cancer Progression.
    Nick Makridakis, Ph.D.
  • Nuclear Matrix Proteins in Disparity of Prostate Cancer.
    Asim Abdel-Mageed, D.V.M., Ph.D.
  • EBV Transcriptomics.
    Erik Flemington, Ph.D.
  • Renal Cell Carcinoma Study.
    Asim Abdel-Mageed, D.V.M., Ph.D.
  • Glioblastoma Project.
    Erik Flemington, Ph.D.
  • Adipose tissue derived stem cell immunosuppressive effects on CD4+ T cells.
    Brian Rowan, Ph.D.

LCRC Biospecimen Core Laboratory